Vor Biopharma Stock Forecast - Naive Prediction

VOR Stock  USD 15.07  1.52  9.16%   
Vor Stock outlook is based on your current time horizon.
As of today, the value of RSI of Vor Biopharma's share price is approaching 46. This entails that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Vor Biopharma, making its price go up or down.

Momentum 46

 Impartial

 
Oversold
 
Overbought
The successful prediction of Vor Biopharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Vor Biopharma and does not consider all of the tangible or intangible factors available from Vor Biopharma's fundamental data. We analyze noise-free headlines and recent hype associated with Vor Biopharma, which may create opportunities for some arbitrage if properly timed.
Using Vor Biopharma hype-based prediction, you can estimate the value of Vor Biopharma from the perspective of Vor Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Vor Biopharma on the next trading day is expected to be 19.91 with a mean absolute deviation of 1.26 and the sum of the absolute errors of 77.93.

Vor Biopharma after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Vor Biopharma to cross-verify your projections.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

Vor Biopharma Additional Predictive Modules

Most predictive techniques to examine Vor price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vor using various technical indicators. When you analyze Vor charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Vor Biopharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Vor Biopharma value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Vor Biopharma Naive Prediction Price Forecast For the 28th of January

Given 90 days horizon, the Naive Prediction forecasted value of Vor Biopharma on the next trading day is expected to be 19.91 with a mean absolute deviation of 1.26, mean absolute percentage error of 2.79, and the sum of the absolute errors of 77.93.
Please note that although there have been many attempts to predict Vor Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Vor Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Vor Biopharma Stock Forecast Pattern

Backtest Vor Biopharma  Vor Biopharma Price Prediction  Buy or Sell Advice  

Vor Biopharma Forecasted Value

In the context of forecasting Vor Biopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Vor Biopharma's downside and upside margins for the forecasting period are 9.28 and 30.54, respectively. We have considered Vor Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
15.07
19.91
Expected Value
30.54
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Vor Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent Vor Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria120.976
BiasArithmetic mean of the errors None
MADMean absolute deviation1.257
MAPEMean absolute percentage error0.0964
SAESum of the absolute errors77.9347
This model is not at all useful as a medium-long range forecasting tool of Vor Biopharma. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Vor Biopharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Vor Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vor Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0010.56
Details
Intrinsic
Valuation
LowRealHigh
0.000.0010.56
Details
Bollinger
Band Projection (param)
LowMiddleHigh
10.4014.1217.84
Details

Vor Biopharma After-Hype Price Density Analysis

As far as predicting the price of Vor Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vor Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vor Biopharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Vor Biopharma Estimiated After-Hype Price Volatility

In the context of predicting Vor Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vor Biopharma's historical news coverage. Vor Biopharma's after-hype downside and upside margins for the prediction period are 0.00 and 10.56, respectively. We have considered Vor Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
15.07
0.00
After-hype Price
10.56
Upside
Vor Biopharma is out of control at this time. Analysis and calculation of next after-hype price of Vor Biopharma is based on 3 months time horizon.

Vor Biopharma Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Vor Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vor Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vor Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.24 
10.63
  0.01 
  0.03 
18 Events / Month
4 Events / Month
In about 18 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
15.07
0.00
0.00 
21,260  
Notes

Vor Biopharma Hype Timeline

On the 27th of January Vor Biopharma is traded for 15.07. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.03. Vor is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.24%. %. The volatility of related hype on Vor Biopharma is about 7932.84%, with the expected price after the next announcement by competition of 15.04. About 44.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 386.86. Vor Biopharma had not issued any dividends in recent years. The entity had 1:20 split on the 19th of September 2025. Considering the 90-day investment horizon the next estimated press release will be in about 18 days.
Check out Historical Fundamental Analysis of Vor Biopharma to cross-verify your projections.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

Vor Biopharma Related Hype Analysis

Having access to credible news sources related to Vor Biopharma's direct competition is more important than ever and may enhance your ability to predict Vor Biopharma's future price movements. Getting to know how Vor Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vor Biopharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
FATEFate Therapeutics(0.05)2 per month 0.00 (0.07) 8.00 (7.56) 20.90 
NKTXNkarta Inc(0.07)7 per month 3.23  0.01  6.64 (5.31) 16.16 
ACTUActuate Therapeutics Common 0.07 6 per month 0.00 (0.12) 5.40 (6.74) 20.01 
ALECAlector(0.05)17 per month 0.00 (0.07) 5.47 (8.33) 49.84 
FBRXForte Biosciences(0.05)2 per month 5.21  0.24  13.16 (8.96) 37.44 
PEPGPepGen 0.07 6 per month 6.04  0.04  10.32 (9.44) 31.03 
ANIXAnixa Biosciences(0.05)2 per month 0.00 (0.06) 8.98 (6.51) 40.89 
APLTApplied Therapeutics(0.05)2 per month 0.00 (0.23) 10.00 (15.73) 83.66 
MCRBSeres Therapeutics(1.12)9 per month 0.00 (0.02) 9.13 (7.64) 54.10 
SPROSpero Therapeutics(0.04)9 per month 2.67  0  3.64 (5.04) 13.07 

Other Forecasting Options for Vor Biopharma

For every potential investor in Vor, whether a beginner or expert, Vor Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vor Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vor. Basic forecasting techniques help filter out the noise by identifying Vor Biopharma's price trends.

Vor Biopharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vor Biopharma stock to make a market-neutral strategy. Peer analysis of Vor Biopharma could also be used in its relative valuation, which is a method of valuing Vor Biopharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Vor Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Vor Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vor Biopharma shares will generate the highest return on investment. By undertsting and applying Vor Biopharma stock market strength indicators, traders can identify Vor Biopharma entry and exit signals to maximize returns.

Vor Biopharma Risk Indicators

The analysis of Vor Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vor Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vor stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Vor Biopharma

The number of cover stories for Vor Biopharma depends on current market conditions and Vor Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vor Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vor Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Vor Biopharma Short Properties

Vor Biopharma's future price predictability will typically decrease when Vor Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vor Biopharma often depends not only on the future outlook of the potential Vor Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vor Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.4 M
Cash And Short Term Investments91.9 M

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.